Inside Precision Medicine December 16, 2022
Genetic sequencing has changed out of all recognition since the Human Genome Project was officially completed in 2003. The technology is faster, cheaper and more accurate, but for a long time the market has been dominated by a few large companies. This is now starting to change and these five relative newcomers are bringing change and competition to the industry.
Between 80-90% of the sequencing market is dominated by one company, Illumina. The short-read sequencing specialists have had an annual turnover of $2.5-4.5 billion and produce a wide array of machines that are used by thousands of labs around the world. However, on the long-read side of things, Pacific Biosciences and Oxford Nanopore Technologies are arguably the most prominent companies.
...Today's Sponsors
Today's Sponsor